According to GlobalData’s medical device pipeline database, 15 Angiography Catheters devices are in various stages of development globally. GlobalData’s report Angiography Catheters provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 11 are in active development, while the remaining four are in an inactive stage of development. There are four products in the early stages of development, and the remaining seven are in the late stages of development.
Cardiovascular Devices are used to detect and treat heart and circulatory system related diseases. An angiography catheter is a thin, flexible tube that is inserted into a blood vessel to deliver a contrast material that makes the blood vessels visible on X-ray images. They are made of a variety of materials, including plastic, silicone, and metal. Through angiographic catheters a radio contrast dye is injected into the chambers of the heart for visualization of the vascular system which helps in detection of any abnormalities related to the coronary arteries or cardiac valves.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Angiography Catheters pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Angiography Catheters devices. Overall, most of these Angiography Catheters pipeline devices are being developed by private entities.
Key players involved in the active development of Angiography Catheters include Cook Medical, Medical Device Investments, Merit Medical Systems, Rutgers The State University of New Jersey, Shanghai Bluesail Boyuan Medical Technology, University of Chicago, University of Leicester, University of Nebraska, Vanderbilt University and Vanderbilt University.
For a complete picture of the developmental pipeline for Angiography Catheters devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
